SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference

Rhea-AI Summary

SOPHiA GENETICS (SOPH), a cloud-native software company specializing in data-driven medicine, has announced its participation in two major healthcare conferences in September 2024. Ross Muken, the company's CFO and COO, will present at the 22nd Annual Morgan Stanley Healthcare Conference on September 4 at 1:50 p.m. EDT in New York City.

The following week, Dr. Jurgi Camblong, co-Founder and CEO, will join a panel discussion on AI in Healthcare at the 9th Annual TD Cowen FutureHealth Conference on September 10 at 3:15 p.m. EDT, also in New York City. Both presentations will be webcast live on the SOPHiA GENETICS Investor Relations website, with replays available after the events.

News Market Reaction

+5.26%

1 alert

+5.26% News Effect

On the day this news was published, SOPH gained 5.26%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON and ROLLE, Switzerland, Aug. 28, 2024 /PRNewswire/ -- SOPHiA GENETICS, a cloud-native software company and a leader in data-driven medicine, today announced presentations at the 22^nd Annual Morgan Stanley Healthcare Conference and the 9^th Annual TD Cowen FutureHealth Conference in early September.

Chief Financial Officer and Chief Operating Officer, Ross Muken, will present at the 22^nd Annual Morgan Stanley Healthcare Conference in New York City on Wednesday, September 4, 2024, at 1:50 p.m. EDT.

The following week, co-Founder and Chief Executive Officer, Dr. Jurgi Camblong, will join a Panel Discussion on AI in Healthcare at the 9^th Annual TD Cowen FutureHealth Conference in New York City on Tuesday, September 10, 2024, at 3:15 p.m. EDT.

The presentations will be webcast live on the SOPHiA GENETICS Investor Relations website. Additionally, a replay will be available on the website after its completion.

About SOPHiA GENETICS

SOPHiA GENETICS (Nasdaq: SOPH) is a cloud-native healthcare technology company on a mission to expand access to data-driven medicine by using AI to deliver world-class care to patients with cancer and rare disorders across the globe. It is the creator of SOPHiA DDM™, a platform that analyzes complex genomic and multimodal data and generates real-time, actionable insights for a broad global network of hospital, laboratory, and biopharma institutions.  For more information, visit SOPHiAGENETICS.COM and connect with us on LinkedIn.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/sophia-genetics-to-present-at-the-22nd-annual-morgan-stanley-healthcare-conference-and-9th-annual-td-cowen-futurehealth-conference-302233232.html

SOURCE SOPHiA GENETICS

FAQ

When is SOPHiA GENETICS presenting at the Morgan Stanley Healthcare Conference in 2024?

SOPHiA GENETICS (SOPH) will present at the 22nd Annual Morgan Stanley Healthcare Conference on Wednesday, September 4, 2024, at 1:50 p.m. EDT in New York City.

Who will represent SOPHiA GENETICS at the Morgan Stanley Healthcare Conference?

Ross Muken, Chief Financial Officer and Chief Operating Officer of SOPHiA GENETICS, will present at the Morgan Stanley Healthcare Conference.

What event is SOPHiA GENETICS participating in on September 10, 2024?

SOPHiA GENETICS (SOPH) will participate in a Panel Discussion on AI in Healthcare at the 9th Annual TD Cowen FutureHealth Conference on September 10, 2024, at 3:15 p.m. EDT in New York City.

Can investors watch SOPHiA GENETICS' presentations at these healthcare conferences?

Yes, the presentations will be webcast live on the SOPHiA GENETICS Investor Relations website. Replays will also be available on the website after the events.